Your Challenges Require Smart Solutions:
PharmaPharmacelsus - Preclinical Services

Preclinical Services

Your partner for preclinical drug discovery and developtment

Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.

Hit-to-Lead and Lead Optimization

The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.

Preclinical and clinical services CRO

Download Flyer

The experienced and highly committed Pharmacelsus team offers a variety of different services the following in Areas.

In vitro ADME


In vivo DMPK

In vitro & in vivo Toxicology

G(C)LP & non-GLP Bioanalytics

Biomarker Services

In vitro & in vivo Pharmacology

Services for Biologics

GBA Group Pharma

Your contact at Pharmacelsus

MUDr. Maria Li
Director Business Development
Mobile: +49 173 889 4288

Business Development

Contact us!

To learn more about us and what we can do for you please contact our Director Business Development.


GBA Group Pharma Newsletter

Always stay up to date and register for our newsletter.

GBA Group Pharma Sites

Pharmacelsus - Präklinische Dienstleistungen

Science Park 2
66123 Saarbrücken

Pharmacelsus - Präklinische Dienstleistungen

Pharmacelsus GmbH

Science Park 2
66123 Saarbrücken

Tel. +49 681 3946 - 7510
Fax +49 681 3946 - 7511

Member of GBA Group Pharma since 2017.

© 2020 GBA Group
Data PrivacyLegal NoticeTerms & ConditionsDisclosure